A Roche arthritis drug fails in COVID-19, casting doubt on a strained hypothesis
Roche's anti-inflammatory drug Actemra did not help patients hospitalized with severe COVID-19-associated pneumonia, according to Phase 3 results announced by the Swi...
Continue Reading →
